Data / Form D filings / DNATRIX INC
DNATRIX INC: Form D filings
DNATRIX INC, a biotechnology company in Houston, TX, filed 4 Form D notices with the SEC between 2012 and 2018. The latest, on September 25, 2018, reports $15.5 million sold of a $41.2 million offering to 40 investors.
Find out what DNATRIX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 Holcombe Blvd., Suite X+200, Houston, TX, 77021
- Phone
- (832) 930-2401
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1446505
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2018 | New notice | $41,195,960 | $15,529,295 | $25,666,665 | 40 | Sep 12, 2018 | sec.gov |
| Oct 17, 2014 | New notice | $18,800,000 | $12,781,419 | $6,018,581 | 31 | Oct 6, 2014 | sec.gov |
| Nov 7, 2013 | New notice | $3,000,000 | $1,543,905 | $1,456,095 | 13 | Oct 25, 2013 | sec.gov |
| Aug 3, 2012 | New notice | $885,620 | $885,620 | $0 | 10 | Jul 20, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Drew Patrick Pardoll | Director | |
| Brian Patrick Mooney | Executive Officer | |
| Daniel Watkins | Director | |
| Francis Patrick McCormick | Director | |
| Frank Tufaro | Executive Officer, Director | |
| Isaac Patrick Cheng | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Sep 24, 2018 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what DNATRIX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.